High serum galectin-3 in advanced melanoma: Preliminary results

Clinical and Experimental Dermatology

Volumn 31, Issue 1, 2006, Pages 105-109

  Vereecken, P ^a,b,c   Zouaoui Boudjeltia, K ^c   Debray, C ^d   Awada, A ^b   Legssyer, I ^e   Sales, F ^b   Petein, M ^f   Vanhaeverbeek, M ^c   Ghanem, G ^b   Heenen, M ^a  

^a ERASME HOSPITAL   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

^c Experimental Medicine Laboratory   (Belgium)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

^e IBMM   (Belgium)

^f Institute of Pathology and Genetics Gosselies   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GALECTIN 3; LACTATE DEHYDROGENASE; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; FEMALE; HUMAN; MALE; MELANOMA; METASTASIS; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; SKIN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; GALECTIN 3; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; SKIN NEOPLASMS; STATISTICS, NONPARAMETRIC;

EID: 33646091536     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01992.x     Document Type: Article

References (24)

1. Barondes SH, Castronovo V, Cooper DN et al. Galectins. a family of animal beta-galactoside-binding lectins. Cell 1994; 76: 597-8.
2. Loris R. Principles of structures of animal and plant lectins. Biochim Biophys Acta 2002; 1572: 198-208.
3. Ochieng J, Green B, Evans S et al. Modulation of the biological functions of galectin-3 by matrix metalloprotein-ases. Biochim Biophys Acta 1998; 1379: 97-106.
4. Hughes RC. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1999; 1473: 172-85.
5. Yang RY, Liu FT. Galectins in cell growth and apoptosis. Cell Mol Life Sci 2003; 60: 267-76.
6. Barondes SH, Cooper DNW, Gitt MA et al. Galectins. structure and function of a large family of animal lectins. J Biol Chem 1994; 269: 20807-10.
7. Debray C, Vereecken P, Belot N et al. Multifaceted role of galectin-3 on human glioblastoma cell motility. Biochem Biophys Res Commun 2004; 325: 1393-8.
8. Takenaka Y, Fukumori T, Raz A. Galectin-3 and metastasis. Glyconj J 2004; 19: 543-9.
9. Sulaimon SS, Kitchell BE. The basic biology of malignant melanoma: molecular mechanisms of disease progression and comparative aspects. J Vet Intern Med 2003; 17: 760-72.
10. Alonso SR, Ortiz P, Pollan M et al. Progression in cutaneous malignant melanoma is associated with distinct expression profiles. Am J Pathol 2004; 164: 193-203.
11. Balch CM, Buzaid AC, Soong SJ et al. Final version of the American-Joint Committee on Cancer staging sytem for cutaneous melanoma. J Clin Oncol 2001; 19: 3622-34.
12. Buer J, Probst M, Franzke A et al. Elevated serum levels of S100 and survival in metastatic malignant melanoma. Br J Cancer 1997; 75: 1373-6.
13. Brochez L, Naeyaert JM. Serological markers for melanoma. Br J Dermatol 2000; 143: 256-68.
14. Deichmann M, Kahle B, Moser K et al. Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase. Br J Cancer 2004; 91: 699-702.
15. Hoon DSB, Bostick P, Kuo PC et al. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res 2000; 60: 2253-7.
16. Rubinstein N, Ilarregui JM, Toscano MA et al. The role of galectins in the initiation, amplification and resolution of the inflammatory response. Tissue Antigens 2004; 64: 1-12.
17. Almkvist J, Karlsson A. Galectins as inflammatory mediators. Glycoconj J 2004; 19: 575-81.
18. Rabinovich GA, Baum LG, Tinari N et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response. Trends Immunol 2002; 23: 313-20.
19. May A, Berthier-Vergnes O, Apoil PA et al. Expression of the galactose binding protein Mac-2 by human melanoma cell lines. Cancer Lett 1994; 81: 155-63.
20. Iurisci I, Tinari N, Natoli C et al. Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res 2000; 6: 1389-93.
21. Califice S, Castronovo V, Van Den Brule F. Galectin-3 and cancer. Int J Oncol 2004; 25: 983-92.
22. Akahani S, Inohara H, Nangia-Makker P et al. Galectin-3 in tumor metastasis. Trends Glycosci Glycotechnol 1997; 9: 69-75.
23. Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 1998; 76: 402-12.
24. Rubinstein N, Alvarez M, Zwirner NW et al. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege. Cancer Cell 2004; 5: 241-51.